Quetiapine for Mania In Preschool Children 4 to 6 Years of Age With Bipolar Disorder
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This is an 8-week open-label study aimed at assessing the effectiveness and tolerability of
Quetiapine, in the treatment of preschool children aged 4 to 6 years with bipolar and bipolar
spectrum disorder. This is an exploratory, pilot study, seeking to determine whether
Quetiapine is efficacious and well tolerated in the treatment of preschoolers with pediatric
bipolar and bipolar spectrum disorder in this age group. The study results will be used to
generate hypotheses for a larger randomized controlled clinical trial with explicit
hypotheses and sufficient statistical power.